Mucosal bacterial immunotherapy with MV130 highly reduces the need of tonsillectomy in adults with recurrent tonsillitis

References

• El Hennawi DED, Geneid A, Zaher S, Ahmed MR. Management of recurrent tonsillitis in children. Am J Otolaryngol. 2017;38(4):371–74. doi:10.1016/j.amjoto.2017.03.001.
   PubMed Web of Science ®Google Scholar
• Deutsch ES. Tonsillectomy and adenoidectomy. Changing indications. Pediatr Clin North Am. 1996;43:1319–38.
   PubMed Web of Science ®Google Scholar
• Hoddeson EK, Gourin CG. Adult tonsillectomy: current indications and outcomes. Otolaryngol Head Neck Surg. 2009;140(1):19–22. doi:10.1016/j.otohns.2008.09.023.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya N, Kepnes LJ. Economic benefit of tonsillectomy in adults with chronic tonsillitis. Ann Otol Rhinol Laryngol. 2002;111(11):983–88. doi:10.1177/000348940211101106.
   PubMed Web of Science ®Google Scholar
• Magdalena ML, Caragol L, Sole A, Suarez V, Cillero JA, Rodrigo JP. Protocolo específico para el control del dolor postamigdalectomía en los adultos intervenidos en régimen ambulatorio. Acta Otorrinolaringol Esp. 2013;64(3):211–16. doi:10.1016/j.otorri.2012.11.007.
   PubMedGoogle Scholar
• Leong SC, Karkos PD, Papouliakos SM, Apostolidou MT. Unusual complications of tonsillectomy: a systematic review. Am J Otolaryngol. 2007;28(6):419–22. doi:10.1016/j.amjoto.2006.10.016.
   PubMed Web of Science ®Google Scholar
• Cohen D, Dor M. Morbidity and mortality of post-tonsillectomy bleeding: analysis of cases. J Laryngol Otol. 2008;122(1):88–92. doi:10.1017/S0022215107006895.
   PubMed Web of Science ®Google Scholar
• Bellanti JA, Settipane RA. Bacterial vaccines and the innate immune system: a journey of rediscovery for the allergist-immunologist and all health care providers. Allergy Asthma Proc. 2009;30(Suppl 1):S3–4. doi:10.2500/aap.2009.30.3251.
   PubMedGoogle Scholar
• Del-Rio-Navarro BE, Espinosa-Rosales FJ, Flenady V, Sienra-Monge JL. Cochrane review: immunostimulants for preventing respiratory tract infection in children. Evid Based Child Health. 2012;7(2):629–717. doi:10.1002/ebch.1833.
   Google Scholar
• Alecsandru D, Valor L, Sanchez-Ramon S, Gil J, Carbone J, Navarro J, Rodríguez JJ, Rodríguez-Sainz C, Fernández-Cruz E. Sublingual therapeutic immunization with a polyvalent bacterial preparation in patients with recurrent respiratory infections: immunomodulatory effect on antigen-specific memory CD4+ T cells and impact on clinical outcome. Clin Exp Immunol. 2011;164(1):100–07. doi:10.1111/cei.2011.164.issue-1.
   PubMed Web of Science ®Google Scholar
• Chaturvedi VN, Methwani A, Chaturvedi P, Narang P. Bacterial flora in chronic tonsillitis. Indian Pediatr. 1989;26:52–56.
   PubMedGoogle Scholar
• Aznabaeva LF, Aref’eva NA, Gumerova MI. Immune reactions of palatine tonsils in the patients with chronic tonsillitis and the possibilities for their immunological rehabilitation with the use of imudon. Vestn Otorinolaringol. 2012;6:67–70.
   Google Scholar
• Bitar MA, Saade R. The role of OM-85 BV (Broncho-Vaxom) in preventing recurrent acute tonsillitis in children. Int J Pediatr Otorhinolaryngol. 2013;77(5):670–73. doi:10.1016/j.ijporl.2013.01.009.
   PubMed Web of Science ®Google Scholar
• Blander JM, Medzhitov R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature. 2006;440(7085):808–12. doi:10.1038/nature04596.
   PubMed Web of Science ®Google Scholar
• Blander JM, Sander LE. Beyond pattern recognition: five immune checkpoints for scaling the microbial threat. Nat Rev Immunol. 2012;12(3):215–25. doi:10.1038/nri3167.
   PubMed Web of Science ®Google Scholar
• Sato S, Nomura F, Kawai T, Takeuchi O, Muhlradt PF, Takeda K, Akira S. Synergy and cross-tolerance between toll-like receptor (TLR) 2- and TLR4-mediated signaling pathways. J Immunol. 2000;165(12):7096–101. doi:10.4049/jimmunol.165.12.7096.
   PubMed Web of Science ®Google Scholar
• Negri DR, Riccomi A, Pinto D, Vendetti S, Rossi A, Cicconi R, Ruggiero P, Del Giudice G, De Magistris MT. Persistence of mucosal and systemic immune responses following sublingual immunization. Vaccine. 2010;28(25):4175–80. doi:10.1016/j.vaccine.2010.04.013.
   PubMed Web of Science ®Google Scholar
• Cuburu N, Kweon MN, Song JH, Hervouet C, Luci C, Sun JB, Hofman P, Holmgren J, Anjuère F, Czerkinsky C. Sublingual immunization induces broad-based systemic and mucosal immune responses in mice. Vaccine. 2007;25(51):8598–610. doi:10.1016/j.vaccine.2007.09.073.
   PubMed Web of Science ®Google Scholar
• Holmgren J, Czerkinsky C. Mucosal immunity and vaccines. Nat Med. 2005;11(4 Suppl):S45–53. doi:10.1038/nm1213.
   PubMed Web of Science ®Google Scholar
• Benito-Villalvilla C, Cirauqui C, Diez-Rivero CM, Casanovas M, Subiza JL, Palomares O. MV140, a sublingual polyvalent bacterial preparation to treat recurrent urinary tract infections, licenses human dendritic cells for generating Th1, Th17, and IL-10 responses via Syk and MyD88. Mucosal Immunol. 2016;10(4):924–935. doi: 10.1038/mi.2016.112. Epub 2016 Dec 14.
   PubMed Web of Science ®Google Scholar
• Allam JP, Stojanovski G, Friedrichs N, Peng W, Bieber T, Wenzel J, Novak N. Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy? Allergy. 2008;63(6):720–27. doi:10.1111/j.1398-9995.2007.01611.x.
   PubMed Web of Science ®Google Scholar
• Servicio_Cántabro_de_Salud. 2011. Allergy. 2008 Jun;63(6):720–7. doi: 10.1111/j.1398-9995.2007.01611.x. http://www.scsalud.es
   Google Scholar
• Sistema_de_Salud_de_Aragón. Costes medios sanitarios. 2010. http://www.saludinforma.es
   Google Scholar
• Cenjor C, García-Rodríguez JA, Ramos A, Cervera J, Tomás M, Asensi F, Cañada JL, Gobernado M, Isasiá T, López-Madroñero C, et al. Patient consent to “antimicrobial treatment of tonsillitis”. Acta Otorrinolaringol Esp. 2003;54:369–83.
   PubMedGoogle Scholar